Weng Khong Lim

Weng Khong Lim

Auto-generated profile, based on publicly available information

Weng Khong Lim

SingHealth Duke-NUS Institute of Precision Medicine, Singapore Health Services, Singapore, Singapore

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2017 in Nature Genetics
Verified
Journal Article
Open access
BTBin Tean Teh
Bin Tean Teh
KLKevin Lim
Kevin Lim
CYChern Han Yong
Chern Han Yong
CNCedric Chuan Young Ng
Cedric Chuan Young Ng
SRSushma Ramesh Rao
Sushma Ramesh Rao
PTPatrick Tan
Patrick Tan
Durian (Durio zibethinus) is a Southeast Asian tropical plant known for its hefty, spine-covered fruit and sulfury and onion-like odor. Here we present a draft genome assembly of D. zibethinus, representing the third plant genus in the Malvales order and first in the Helicteroideae subfamily to be sequenced. Single-molecule sequencing and chromosome contact maps enabled assembly of the highly heterozygous durian genome at chromosome-scale resolution. Transcriptomic analysis showed upregulation of sulfur-, ethylene-, and lipid-related pathways in durian fruits. We observed paleopolyploidization events shared by durian and cotton and durian-specific gene expansions in MGL (methionine γ-lyase), associated with production of volatile sulfur compounds (VSCs). MGL and the ethylene-related gene ACS (aminocyclopropane-1-carboxylic acid synthase) were upregulated in fruits concomitantly with their downstream metabolites (VSCs and ethylene), suggesting a potential association between ethylene biosynthesis and methionine regeneration via the Yang cycle. The durian genome provides a resource for tropical fruit biology and agronomy.

2 June 2023 in Science
Verified
Journal Article
Closed access
LKLukas Kuderna
Lukas Kuderna
HGHong Gao
Hong Gao
MJMareike Janiak
Mareike Janiak
MKMARTIN KUHLWILM
MARTIN KUHLWILM
JOJoseph D. Orkin
Joseph D. Orkin
TMTomas Marques
Tomas Marques
The rich diversity of morphology and behavior displayed across primate species provides an informative context in which to study the impact of genomic diversity on fundamental biological processes. Analysis of that diversity provides insight into long-standing questions in evolutionary and conservation biology and is urgent given severe threats these species are facing. Here, we present high-coverage whole-genome data from 233 primate species representing 86% of genera and all 16 families. This dataset was used, together with fossil calibration, to create a nuclear DNA phylogeny and to reassess evolutionary divergence times among primate clades. We found within-species genetic diversity across families and geographic regions to be associated with climate and sociality, but not with extinction risk. Furthermore, mutation rates differ across species, potentially influenced by effective population sizes. Lastly, we identified extensive recurrence of missense mutations previously thought to be human specific. This study will open a wide range of research avenues for future primate genomic research.

2 June 2023 in Science
Verified
Journal Article
Closed access
HGHong Gao
Hong Gao
THTobias Hamp
Tobias Hamp
JEJeffrey Ede
Jeffrey Ede
JSJoshua G. Schraiber
Joshua G. Schraiber
JMJeremy McRae
Jeremy McRae
KFKyle Kai-How Farh
Kyle Kai-How Farh
Personalized genome sequencing has revealed millions of genetic differences between individuals, but our understanding of their clinical relevance remains largely incomplete. To systematically decipher the effects of human genetic variants, we obtained whole-genome sequencing data for 809 individuals from 233 primate species and identified 4.3 million common protein-altering variants with orthologs in humans. We show that these variants can be inferred to have nondeleterious effects in humans based on their presence at high allele frequencies in other primate populations. We use this resource to classify 6% of all possible human protein-altering variants as likely benign and impute the pathogenicity of the remaining 94% of variants with deep learning, achieving state-of-the-art accuracy for diagnosing pathogenic variants in patients with genetic diseases.

22 February 2017 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
LLLian Dee Ler
Lian Dee Ler
SUJOY GHOSHSUJOY GHOSH
SUJOY GHOSH
XCXiaoran Chai
Xiaoran Chai
ATAye Aye Thike
Aye Aye Thike
HHHong Lee Heng
Hong Lee Heng
BTBin Tean Teh
Bin Tean Teh
Trithorax-like group complex containing KDM6A acts antagonistically to Polycomb-repressive complex 2 (PRC2) containing EZH2 in maintaining the dynamics of the repression and activation of gene expression through H3K27 methylation. In urothelial bladder carcinoma, KDM6A (a H3K27 demethylase) is frequently mutated, but its functional consequences and therapeutic targetability remain unknown. About 70% of KDM6A mutations resulted in a total loss of expression and a consequent loss of demethylase function in this cancer type. Further transcriptome analysis found multiple deregulated pathways, especially PRC2/EZH2, in KDM6A-mutated urothelial bladder carcinoma. Chromatin immunoprecipitation sequencing analysis revealed enrichment of H3K27me3 at specific loci in KDM6A-null cells, including PRC2/EZH2 and their downstream targets. Consequently, we targeted EZH2 (an H3K27 methylase) and demonstrated that KDM6A-null urothelial bladder carcinoma cell lines were sensitive to EZH2 inhibition. Loss- and gain-of-function assays confirmed that cells with loss of KDM6A are vulnerable to EZH2. IGFBP3, a direct KDM6A/EZH2/H3K27me3 target, was up-regulated by EZH2 inhibition and contributed to the observed EZH2-dependent growth suppression in KDM6A-null cell lines. EZH2 inhibition delayed tumor onset in KDM6A-null cells and caused regression of KDM6A-null bladder tumors in both patient-derived and cell line xenograft models. In summary, our study demonstrates that inactivating mutations of KDM6A, which are common in urothelial bladder carcinoma, are potentially targetable by inhibiting EZH2.

29 November 2023 in Nature
Verified
Journal Article
Open access
PDF file
LKLukas Kuderna
Lukas Kuderna
JUJacob C. Ulirsch
Jacob C. Ulirsch
SRSabrina Rashid
Sabrina Rashid
MAMohamed Ameen
Mohamed Ameen
LSLaksshman Sundaram
Laksshman Sundaram
KFKyle Kai-How Farh
Kyle Kai-How Farh
Noncoding DNA is central to our understanding of human gene regulation and complex diseases1,2, and measuring the evolutionary sequence constraint can establish the functional relevance of putative regulatory elements in the human genome3–9. Identifying the genomic elements that have become constrained specifically in primates has been hampered by the faster evolution of noncoding DNA compared to protein-coding DNA10, the relatively short timescales separating primate species11, and the previously limited availability of whole-genome sequences12. Here we construct a whole-genome alignment of 239 species, representing nearly half of all extant species in the primate order. Using this resource, we identified human regulatory elements that are under selective constraint across primates and other mammals at a 5% false discovery rate. We detected 111,318 DNase I hypersensitivity sites and 267,410 transcription factor binding sites that are constrained specifically in primates but not across other placental mammals and validate their cis-regulatory effects on gene expression. These regulatory elements are enriched for human genetic variants that affect gene expression and complex traits and diseases. Our results highlight the important role of recent evolution in regulatory sequence elements differentiating primates, including humans, from other placental mammals.

19 January 2023 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
EWEleanor Wong
Eleanor Wong
NBNicolas Bertin
Nicolas Bertin
MHMaxime Hebrard
Maxime Hebrard
RTRoberto Tirado-Magallanes
Roberto Tirado-Magallanes
CBClaire Bellis
Claire Bellis
DKDimitar Kenanov
Dimitar Kenanov